Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | THRB | P10828 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.68 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | CTSC | P53634 | 1/20 | 0.56 |
| ▸ | ANPEP | P15144 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30581396 | 1.00 | OPRK1 (0.69) | OPRK1ALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL28231245 | 1.00 | OPRK1 (0.69) | OPRK1ALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL30581395 | 1.00 | OPRK1 (0.69) | OPRK1ALDH1A1THRBCYP2C9CYP2C19 | |
| Bromide SCHEMBL11571243 | 0.99 | OPRK1 (0.67) | OPRK1ALDH1A1THRBCYP2C9CYP2C19 | |
| Hydrochloric Acid SCHEMBL29661828 | 0.99 | OPRK1 (0.67) | OPRK1ALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL20885112 | 0.97 | OPRK1 (0.66) | OPRK1ALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL11597665 | 0.93 | TSHR (0.67) | OPRK1ALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL10394119 | 0.93 | TSHR (0.67) | OPRK1ALDH1A1THRBCYP2C9CYP2C19 | |
| Trifluoroacetic Acid SCHEMBL11579813 | 0.93 | OPRK1 (0.62) | OPRK1ALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL11359300 | 0.93 | TSHR (0.67) | OPRK1ALDH1A1THRBCYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250127167-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2025-04-24 | — | — | US | claimed |
| WO-2024261749-A1 | ANTIMICROBIAL PEPTIDE-METAL COMPLEXES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2024-12-26 | — | — | WO | claimed |
| EP-4401555-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2024-07-24 | — | — | EP | claimed |
| US-20240206465-A1 | ACTIVE POLYMERIC FILMS AND POLYMERIC COMPOSITIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2024-06-27 | — | — | US | claimed |
| EP-4326064-A1 | ACTIVE POLYMERIC FILMS AND POLYMERIC COMPOSITIONS | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2024-02-28 | — | — | EP | claimed |
| CN-116046861-A | Manufacturing method of electrochemical sensor for promoting electron transfer | 深圳可孚生物科技有限公司 | 2023-05-02 | — | — | CN | claimed |
| WO-2023042201-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2023-03-23 | — | — | WO | claimed |
| WO-2022224247-A1 | ACTIVE POLYMERIC FILMS AND POLYMERIC COMPOSITIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2022-10-27 | — | — | WO | claimed |
| WO-2026099867-A1 | SUSTAINABLE ANTIFREEZE COATINGS BY PEPTIDE SELF-ASSEMBLY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2026-05-15 | — | — | WO | disclosed |
| US-20250313594-A1 | TWO-RESIDUE-EXTENDED PEPTIDE AND METHOD FOR PRODUCING SAME | NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP) | 2025-10-09 | — | — | US | disclosed |
| US-20250127167-A1 | ANTIMICROBIAL PEPTIDES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2025-04-24 | — | — | US | disclosed |
| US-20250092088-A1 | PEPTIDE COMPOUND PRODUCTION METHOD | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2025-03-20 | — | — | US | disclosed |
| WO-2024261749-A1 | ANTIMICROBIAL PEPTIDE-METAL COMPLEXES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2024-12-26 | — | — | WO | disclosed |
| CN-113366011-B | Process for producing peptide compound | 日产化学株式会社 | 2024-08-16 | — | — | CN | disclosed |
| US-5214145-A | Trisubstituted piperazin-2,5-diones | EASTMAN KODAK COMPANY (US) | 1993-05-25 | — | — | US | disclosed |
| US-5002872-A | Peptides, Liquid Phase, Acetonitrile, Water | W. R. GRACE & CO.-CONN. (US) | 1991-03-26 | — | — | US | disclosed |
| US-4992552-A | Process for preparation of amino acids | EASTMAN KODAK COMPANY (US) | 1991-02-12 | — | — | US | disclosed |
| EP-0272564-A2 | Enzyme mediated coupling reactions | HAMPSHIRE CHEMICAL CORPORATION (US) | 1988-06-29 | — | — | EP | disclosed |
| US-4382889-A | Epoxysuccinic acid derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1983-05-10 | — | — | US | disclosed |
| US-4333879-A | CALCIUM-ACTIVATED NEUTRAL THIOLPROTEASE INHIBITOR USED IN THE TREATMENT OF MUSCULAR DYSTROPHY | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1982-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240206465-A1 | ACTIVE POLYMERIC FILMS AND POLYMERIC COMPOSITIONS | PUF60, PARG, PGLS | OPRK1 4359/4885ALDH1A1 4377/4885THRB 4617/4885 |
| US-20250092088-A1 | PEPTIDE COMPOUND PRODUCTION METHOD | VIP, NPPA, HM13 | OPRK1 4094/4885ALDH1A1 4107/4885THRB 1258/4885 |
| US-20250313594-A1 | TWO-RESIDUE-EXTENDED PEPTIDE AND METHOD FOR PRODUCING SAME | NPPA, NGLY1, ANPEP | OPRK1 3433/4885ALDH1A1 3754/4885THRB 571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.